Evidence map›Paper›PMID 25847964›Full record

ArticleInfection and immunity2015

AMA1-deficient Toxoplasma gondii parasites transiently colonize mice and trigger an innate immune response that leads to long-lasting protective immunity.

Vanessa Lagal, Márcia Dinis, Dominique Cannella, Daniel Bargieri, Virginie Gonzalez, Nicole Andenmatten, Markus Meissner, Isabelle Tardieux

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 29 citations in OpenAlex.

  1. Role ofMicrobiology spectrum · 2026
    Article
  2. The live attenuatedResearch square · 2026
    Article
  3. Therapeutic effect of baicalein as an antiparasitic agent againstJournal of Zhejiang University. Science. B · 2025
    Article
  4. Article
  5. Invasion ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Deletion ofBiomedicines · 2022
    Article
  7. Advances inVaccines · 2021
    Review
  8. Frontiers in microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Key Limitations and New Insights Into theFrontiers in cellular and infection microbiology · 2020
    Review
  13. Article
  14. Article
  15. Kinetics of Mimivirus Infection Stages Quantified Using Image Flow Cytometry.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2019
    Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Vanessa LagalINSERM U1016, Institut Cochin, Paris, France CNRS UMR8104, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Márcia DinisINSERM U1016, Institut Cochin, Paris, France CNRS UMR8104, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Dominique CannellaCNRS UMR5163, LAPM, Grenoble, France Université Joseph Fourier, Grenoble, France.
Daniel BargieriInstitut Pasteur, Paris, France.
Virginie GonzalezINSERM U1016, Institut Cochin, Paris, France CNRS UMR8104, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
Nicole AndenmattenWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow, Lanarkshire, United Kingdom.
Markus MeissnerWellcome Trust Centre for Molecular Parasitology, Institute of Infection, Immunity Inflammation, College of Medical, Veterinary and Life Sciences, Glasgow, Lanarkshire, United Kingdom.
Isabelle TardieuxINSERM U1016, Institut Cochin, Paris, France CNRS UMR8104, Paris, France Université Paris Descartes, Sorbonne Paris Cité, Paris, France isabelle.tardieux@inserm.fr.
Inserm · FRWellcome Centre for Molecular Parasitology · GBDélégation Paris 5 · FRInstitut Pasteur · FRSorbonne Paris Cité · FRUniversité Joseph Fourier · FR

Funding

Wellcome Trust 087582Wellcome Trust 103875Wellcome Trust 104111
6 · The paper itself

Abstract

The apical membrane antigen 1 (AMA1) protein was believed to be essential for the perpetuation of two Apicomplexa parasite genera, Plasmodium and Toxoplasma, until we genetically engineered viable parasites lacking AMA1. The reduction in invasiveness of the Toxoplasma gondii RH-AMA1 knockout (RH-AMA1(KO)) tachyzoite population, in vitro, raised key questions about the outcome associated with these tachyzoites once inoculated in the peritoneal cavity of mice. In this study, we used AMNIS technology to simultaneously quantify and image the parasitic process driven by AMA1(KO) tachyzoites. We report their ability to colonize and multiply in mesothelial cells and in both resident and recruited leukocytes. While the RH-AMA1(KO) population amplification is rapidly lethal in immunocompromised mice, it is controlled in immunocompetent hosts, where immune cells in combination sense parasites and secrete proinflammatory cytokines. This innate response further leads to a long-lasting status immunoprotective against a secondary challenge by high inocula of the homologous type I or a distinct type II T. gondii genotypes. While AMA1 is definitively not an essential protein for tachyzoite entry and multiplication in host cells, it clearly assists the expansion of parasite population in vivo.

Indexed as

AnimalsAntibodies, ProtozoanAntigens, ProtozoanFemaleGenesImmunity, InnateImmunocompromised HostMacrophages, PeritonealMiceMice, Inbred StrainsProtozoan VaccinesToxoplasmaToxoplasmosis, AnimalVaccines, AttenuatedVirulenceAMA1 protein, Toxoplasma gondiiAntibodies, ProtozoanAntigens, ProtozoanProtozoan VaccinesVaccines, Attenuated

Identifiers

PMID25847964
PMCPMC4432741
OpenAlexW1997041961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.